AbbVie
Court rules against EMA disclosure
May 2, 2013Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Roche, transparency
The European Medicines Agency (EMA) has been ordered in an interim ruling by the General Court of the European Union …
Sales rise for AbbVie
April 30, 2013Sales and Marketing AbbVie, Abbott
AbbVie has released its first financial results as a standalone company since separating from Abbott as an $18 billion biopharma …
AbbVie guards Humira data
March 13, 2013Sales and Marketing AbbVie, Abbott, Humira, RA, transparency
AbbVie has issued two injunctions against the European Medicines Agency to prevent the regulator revealing data about rheumatoid arthritis drug …
Abbott seeks leukemia test
February 25, 2013Sales and Marketing AbbVie, Abbott, Janssen
Abbott is to team up with Janssen Biotech and biopharma firm Pharmacyclics to seek a diagnostic test for leukemia patients. …
Abbott finishes strongly before spin-off
January 25, 2013Sales and Marketing AbbVie, Abbott, Q4 2012
Abbott has presented its full-year results for 2012 – the last in which many of its products will appear, following …
AbbVie splits from Abbott
January 7, 2013Sales and Marketing AbbVie, Abbott, HIV, Humira
AbbVie, the new $18 billion biopharma company which includes many of Abbott’s most high profile products, has finally launched. Abbott …
Humira powers ahead as Abbott prepares split
July 19, 2012Sales and Marketing AbbVie, Abbott, Humira, RA
Humira maintained its rapid growth in the second quarter, helping keep Abbott buoyant ahead of its split into two separate …
Analysts want AstraZeneca-AbbVie tie-up
June 20, 2012Sales and Marketing AbbVie, Abbott, AstraZeneca, merger
Analysts want Abbott’s new spin-off firm AbbVie to merge with the troubled AstraZeneca, saying it could give both firms future …
Abbott sets out AbbVie stall for shareholders
June 12, 2012Manufacturing and Production AbbVie, Abbott, CRO, Taylor, manufacturing
Abbott Laboratories has issued the prospectus for its planned separation of its pharmaceutical operations into a standalone company called AbbVie …
Abbott pays $1.6 billion to settle Depakote claims
May 8, 2012Medical Communications, Sales and Marketing AbbVie, Abbott, CIA, Depakote
Abbott will pay $1.6 billion to settle US legal claims over its epilepsy drug Depakote. The $1.6 billion will settle …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
